Inside Drug Pricing - 10/29/2018

Azar: Price Referencing Decided, Other Details Open To Feedback

October 26, 2018
HHS Secretary Alex Azar said President Donald Trump is not backing down from an advance notice of proposed rulemaking that would pilot international price referencing for Medicare Part B drugs. In his appearance at the Brookings Institution Friday (Oct. 26), Azar said that the administration is, however, open to suggestions on how to implement the demo. “This President is not turning back: We will put American patients first by reforming how Part B pays for drugs, and this reference pricing...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.